Bacterial strain lacticaseibacillus paracasei cm 4.2 – producer of exopolysaccharides
KZ38384BUndetermined Publication Date: 2026-11-06NON PROFIT JOINT CO KAZAKH AGROTECHNICAL RES UNIV NAMED AFTER SAKEN SEIFULLIN
0 Cites 0 Cited by
Patent Information
- Application Number
- KZ20250728
- Authority / Receiving Office
- KZ · KZ
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-08-04
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2045-08-04
Abstract
The invention relates to microbiology, food and medical biotechnology, veterinary science, and agriculture. A new microorganism strain, Lacticaseibacillus paracasei CM 4.2, isolated from camel milk, is presented. It has the ability to synthesize exopolysaccharides (EPS) and exhibits antagonistic activity against Escherichia coli, Staphylococcus aureus, and Bacillus cereus. The strain is resistant to vancomycin, gentamicin, kanamycin, tetracycline, and chloramphenicol, and sensitive to ampicillin, streptomycin, erythromycin, and clindamycin. It exhibits high autoaggregation and coaggregation capacity. These properties make the strain suitable for use in the development of food products and dietary supplements with probiotic effects based on EPS-producing cultures. Its use not only improves the texture, viscosity, and stability of products but also promotes consumer health through its antibacterial and immunomodulatory effects. The technical result achieved is increased biological activity and improved technological properties of products through the use of an EPS-producing probiotic strain.
Need to check novelty before this filing date? Find Prior Art
